Evidence map›Paper›PMID 28396600›Full record

ArticleScientific reports2017

Endothelial colony forming cells and mesenchymal progenitor cells form blood vessels and increase blood flow in ischemic muscle.

Kyu-Tae Kang, Ruei-Zeng Lin, David Kuppermann, Juan M Melero-Martin, Joyce Bischoff

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Role of Endothelial Progenitor Cells in Frailty.International journal of molecular sciences · 2023
    Review
  15. Human Endothelial Colony-Forming Cells.Cold Spring Harbor perspectives in medicine · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Kyu-Tae KangVascular Biology Program and Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Ruei-Zeng LinDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
David KuppermannVascular Biology Program and Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Juan M Melero-MartinDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Joyce BischoffVascular Biology Program and Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA. joyce.bischoff@childrens.harvard.edu.
Boston Children's Hospital · USHarvard University · USDuksung Women's University · KR

Funding

Blood vessel assembly from multipotent hemangioma-derived stem cellsR01HL096384 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI Joyce E. Bischoff · 2009 to 2026
$7.7M
Tissue Vascularization Using Blood- or Bone-Marrow-derived Progenitor CellsR01HL094262 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI BISCHOFF, JOYCE E. · 2008 to 2011
$2.2M
Engineering vascularized tissue in vivo using postnatal progenitor cellsR00EB009096 · NIBIB · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2011 to 2013
$719k
Host neutrophils as direct mediators of tissue graft revascularizationR21AI123883 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2016 to 2017
$487k
NHLBI NIH HHS R01 HL094262NIBIB NIH HHS R00 EB009096
6 · The paper itself

Abstract

Here we investigated whether endothelial colony forming cells (ECFC) and mesenchymal progenitor cells (MPC) form vascular networks and restore blood flow in ischemic skeletal muscle, and whether host myeloid cells play a role. ECFC + MPC, ECFC alone, MPC alone, or vehicle alone were injected into the hind limb ischemic muscle one day after ligation of femoral artery and vein. At day 5, hind limbs injected with ECFC + MPC showed greater blood flow recovery compared with ECFC, MPC, or vehicle. Tail vein injection of human endothelial specific Ulex europaeus agglutinin-I demonstrated an increased number of perfused human vessels in ECFC + MPC compared with ECFC. In vivo bioluminescence imaging showed ECFC persisted for 14 days in ECFC + MPC-injected hind limbs. Flow cytometric analysis of ischemic muscles at day 2 revealed increased myeloid lineage cells in ECFC + MPC-injected muscles compared to vehicle-injected muscles. Neutrophils declined by day 7, while the number of myeloid cells, macrophages, and monocytes did not. Systemic myeloid cell depletion with anti-Gr-1 antibody blocked the improved blood flow observed with ECFC + MPC and reduced ECFC and MPC retention. Our data suggest that ECFC + MPC delivery could be used to reestablish blood flow in ischemic tissues, and this may be enhanced by coordinated recruitment of host myeloid cells.

Indexed as

Neovascularization, PhysiologicRegional Blood FlowAnimalsEndothelial Progenitor CellsHindlimbHumansIschemiaMaleMesenchymal Stem CellsMiceMusclesMuscle, SkeletalMyeloid Cells

Identifiers

PMID28396600
PMCPMC5429692
OpenAlexW2604574014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.